A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.

Triple-negative breast cancer (TNBC), accounting for 10-15% of all breast malignancies, is more prevalent in women under 40, particularly in those of African descent or carrying the BRCA1 mutation. TNBC is characterized by the absence of estrogen and progesterone receptors (ER, PR) and low or elevat...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Shopnil Akash, Farjana Islam Aovi, Md A K Azad, Ajoy Kumer, Unesco Chakma, Md Rezaul Islam, Nobendu Mukerjee, Md Mominur Rahman, Imren Bayıl, Summya Rashid, Rohit Sharma
स्वरूप: लेख
भाषा:English
प्रकाशित: Public Library of Science (PLoS) 2023-01-01
श्रृंखला:PLoS ONE
ऑनलाइन पहुंच:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283271&type=printable